Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Disease Control Priorities, Third Edition (Volume 3): Cancer

by Hellen Gelband , Prabhat Jha , Rengaswamy Sankaranarayanan
Save 17% Save 17%
Current price ₹4,106.00
Original price ₹4,928.00
Original price ₹4,928.00
Original price ₹4,928.00
(-17%)
₹4,106.00
Current price ₹4,106.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9781464803499
  • Binding: Paperback
  • Subject: N/A
  • Publisher: World Bank Publications
  • Publisher Imprint: World Bank Publications
  • Publication Date:
  • Pages: 360
  • Original Price: GBP 27.99
  • Language: English
  • Edition: 3rd ed
  • Item Weight: 840 grams
  • BISAC Subject(s): Radiology, Radiotherapy & Nuclear Medicine

Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packages that are cost-effective and suited to low-resource settings. Main messages from the volume include: -Quality matters in all aspects of cancer treatment and palliation. -Cancer registries that track incidence, mortality, and survival - paired with systems to capture causes of death are important to understanding the national cancer burden and the effect of interventions over time. -Effective interventions exist at a range of prices. Adopting 'resource appropriate' measures which allow the most effective treatment for the greatest number of people will be advantageous to countries. -Prioritizing resources toward early stage and curable cancers is likely to have the greatest health impact in low income settings. -Research prioritization is no longer just a global responsibility. Providing cancer treatment requires adequate numbers of trained healthcare professionals and infrastructure beyond what is available in most LMICs, especially low income countries. Careful patient monitoring is a requirement of good quality cancer care and this often involves laboratory tests in addition to clinical examination. Even if financing were immediately available to build or expand a cancer control system, reaching capacity will take many years.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us